Samsung Biologics Co.,Ltd.
207940
Rangering i aksjer
#498
Samsung Biologics Co.,Ltd., established in 2011 and headquartered in Incheon,... Samsung Biologics Co.,Ltd., established in 2011 and headquartered in Incheon, South Korea, provides contract services for biopharmaceutical products. The company's operations are divided into two main segments: Contract Manufacturing Organization (CMO) and Contract Development Organization (CDO). Its CDO services cover areas such as cell line development, optimization of upstream and downstream processes, and the formulation of analytical methods and final products. For CMO, the company offers aseptic filling, lyophilization, finishing, storage, shipping, and various associated support services. Additionally, it delivers comprehensive quality assurance, quality control, biosafety, and analytical testing. Samsung Biologics is also involved in creating and launching biosimilar drugs, alongside manufacturing mammalian cell-based antibody medications.
Aksjekurs
$1,028.49
Markedsverdi
$47.88B
Endring (1 dag)
-3.67%
Endring (1 år)
-18.37%
Land
KR
Handel Samsung Biologics Co.,Ltd. (207940)
Kategori
Healthcare
Aksjeprishistorikk for Samsung Biologics Co.,Ltd. (207940)
Høyeste sluttskurs: $917.33 den 2026-10-01
Laveste sluttskurs: $215.60 den 2016-11-01
Laveste sluttskurs: $215.60 den 2016-11-01
Aksjeprishistorikk for Samsung Biologics Co.,Ltd. fra 2016 til 2026
Årlig aksjeprisytelse
| År | Ytelse |
|---|---|
| 2026 (TTM) | -6.12% |
| 2025 | 12.74% |
| 2024 | 21.95% |
| 2023 | -14.64% |
| 2022 | -16.07% |
| 2021 | 2.83% |
| 2020 | 117.47% |
| 2019 | 6.18% |
| 2018 | -1.56% |
| 2017 | 164.22% |
| 2016 | 0.00% |
Aksjepris for lignende selskaper eller konkurrenter
| Selskap | Aksjepris | Endring 1år% | Land |
|---|---|---|---|
| $536.13 | 25.72% |
US
|
|
| $200.12 | 645.31% |
US
|
|
| $137.79 | -3.81% |
AU
|
|
| $291.76 | 2.51% |
BE
|
|
| $880.01 | 8.09% |
NL
|
